Skip to main content

ORIGINAL RESEARCH article

Front. Plant Sci.
Sec. Plant Pathogen Interactions
Volume 15 - 2024 | doi: 10.3389/fpls.2024.1469045
This article is part of the Research Topic Plant Immune Responses, Evolutionary Dynamics, Control and Transmission of plant ssDNA viruses: Volume II View all articles

SEGS-1 episomes generated during cassava mosaic disease enhance disease severity

Provisionally accepted
  • 1 Department of Horticulture, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
  • 2 Department of Plant and Microbial Biology, North Carolina State University, Raleigh, North Carolina, United States
  • 3 Tanzania Agricultural Research Institute (TARI)-Mikocheni, Dar es Salaam, Tanzania
  • 4 BASF Corporation, Energy Tower IV, Houston TX, United States
  • 5 Tanzania Plant Health and Pesticide Authority, Arusha, Tanzania
  • 6 Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, North Carolina, United States

The final, formatted version of the article will be published soon.

    Cassava is an important root crop that is produced by smallholder farmers across Sub-Saharan Africa. Cassava mosaic disease (CMD), which is caused by a group of cassava mosaic begomoviruses (CMBs), is one of the most devastating diseases of cassava. A previous study showed that SEGS-1 (sequences enhancing geminivirus symptoms), which occur both in the cassava genome and as episomes during CMD, can increase CMD disease severity and overcome host resistance. In this report, we examined the effects of exogenously applied SEGS-1 on the incidence of CMB infection, symptom severity, and viral DNA copy number in five cassava cultivars that ranged from highly susceptible to highly resistant to CMD. These studies revealed that the effect of SEGS-1 is cultivar dependent. Susceptible cultivars developed severe CMD with or without exogenous SEGS-1, while exogenous SEGS-1 increased disease severity in cultivars carrying CMD2 resistance, which is conferred by a single locus, but not CMD1 resistance, which is polygenic. Analysis of infected plants in the absence of exogenous SEGS-1 revealed that some, but not all, cultivars form SEGS-1 episomes during CMD. The presence of endogenous SEGS-1 episomes in TME14, a CMD2 resistant cultivar, correlated with CMD severity. In contrast, TME3, a closely related CMD2 cultivar, did not produce endogenous SEGS-1 episomes and was more resistance than TME14. The different capacities of TME3 and TME14 to form SEGS-1 episomes is unlikely due to sequence differences in and around their genomic SEGS-1 loci. The functional regions of SEGS-1 were mapped using TME3 to sequences flanking the episome junction, but the junction itself was not required for activity. All cassava cultivars have SEGS-1 sequences in their genomes that have the potential to negatively impact the development of stable CMD resistance by cassava breeding programs.

    Keywords: Cassava mosaic begomovirus, Cassava mosaic disease, CMD, SEGS-1, Resistance

    Received: 23 Jul 2024; Accepted: 09 Dec 2024.

    Copyright: © 2024 Chiunga, Aimone, Rajabu, Dallas, Ndunguru, Ascencio-Ibáñez, Ateka and Hanley-Bowdoin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Jose T. Ascencio-Ibáñez, Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, 27695, North Carolina, United States
    Linda Hanley-Bowdoin, Department of Plant and Microbial Biology, North Carolina State University, Raleigh, 27695, North Carolina, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.